Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47.6M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
33.4M
-
Shares change
-
-425K
-
Total reported value, excl. options
-
$84.1M
-
Value change
-
+$2.32M
-
Put/Call ratio
-
2.09
-
Number of buys
-
18
-
Number of sells
-
-33
-
Price
-
$2.52
Significant Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q4 2022
65 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares, no par value per share as of Q4 2022.
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.4M shares
of 47.6M outstanding shares and own 70.1% of the company stock.
Largest 10 shareholders include BVF INC/IL (8.75M shares), Bellevue Group AG (7.9M shares), Soleus Capital Management, L.P. (3.87M shares), PFM Health Sciences, LP (3.84M shares), MORGAN STANLEY (2.01M shares), Avidity Partners Management LP (1.86M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.04M shares), Ally Bridge Group (NY) LLC (812K shares), Frazier Life Sciences Management, L.P. (605K shares), and Rock Springs Capital Management LP (525K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.